NCT00141297 · Interventional trial
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
Overall registry status Completed
Phase 1
Conditions Lymphoma, Non-Hodgkin, Neoplasms
Delaware Valley sites
- Abramson Cancer Center Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Pharmacy/PCAM/West Pavillion · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory